Clinical Trial Update: Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating perioperative TAS-102 in combination with oxaliplatin for locally advanced rectal cancer, focusing on event-free survival and pathologi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Qingdao Central Hospital | Conditions: EFS, pCR Rate | Phase 2 | Status: ACTIVE_NOT_RECRUITING